BioSpace News Archive

Oyster Point Pharma, Inc. announced that the Compensation Committee of its Board of Directors granted inducement non-qualified stock options to purchase an aggregate of 177,000 shares of common stock to 110 new employees, pursuant to the Oyster Point Pharma, Inc., 2021 Inducement Incentive Plan.

BioLife Solutions, Inc. announces that it has filed a registration statement on Form S-3 with the Securities and Exchange Commission to register approximately 10.7 million shares of restricted common stock held by stockholders of previously acquired companies Global Cooling, Inc., SciSafe Holdings, Inc. and Sexton Biotechnologies, Inc., as well as certain shares held by Casdin Capital.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that BRUKINSA® (zanubrutinib) has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).

T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens, announced efforts in recognition of Sepis Awareness Month to educate on the importance of rapid diagnostic technologies at a time when sepsis is the most common complication observed in severe cases of COVID-19.1,2

Agilent Technologies Inc. announced that Mike McMullen, Agilent President and CEO, and Bob McMahon, Agilent CFO, will participate in a “fireside chat” discussion at the Wells Fargo Virtual Healthcare Conference Sept. 9.

NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, and Bionano Genomics, based in San Diego, California, have entered into a procurement and collaboration agreement.

ValnevaSE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will participate in 1-on-1 meetings with institutional investors at the Goldman Sachs Eleventh Annual Biotech Symposium on September 7, 2021.

Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a first-of-its-kind microchannel drug delivery technology, recently announced that the company received a notice of allowance through the USPTO’s Fast-Track Prioritized Examination Pilot Program (PEPP) for the application of the company’s proprietary technology for self-injectable Covid 19 vaccination (AQV-1122.)

Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in the following investor healthcare conferences: Citi’s 16th Annual BioPharma Conference.

Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced that the company will participate in the Baird Global Healthcare Virtual Conference on Tuesday, September 14, 2021 at 2:35 PM ET.